| World malaria report 2022 World Health Organization World Health Organization, 2022 | 15783 | 2022 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 8624 | 2017 |
| Classification criteria for Sjögren’s syndrome C Vitali, N Del Papa Sjögren's Syndrome, 47-60, 2016 | 6529 | 2016 |
| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 3476 | 2019 |
| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Annals of the rheumatic diseases 76 (1), 9-16, 2017 | 2775 | 2017 |
| Genetics of rheumatoid arthritis contributes to biology and drug discovery Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ... Nature 506 (7488), 376-381, 2014 | 2623 | 2014 |
| Antimicrobial resistance and the United Nations sustainable development cooperation framework: Guidance for United Nations Country teams World Health Organization World Health Organization, 2021 | 1914 | 2021 |
| Immune-related adverse events of checkpoint inhibitors M Ramos-Casals, JR Brahmer, MK Callahan, A Flores-Chávez, N Keegan, ... Nature reviews Disease primers 6 (1), 38, 2020 | 1109 | 2020 |
| EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Annals of the rheumatic diseases 69 (6), 1103-1109, 2010 | 1043 | 2010 |
| Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection O Hermine, F Lefrère, JP Bronowicki, X Mariette, K Jondeau, ... New England Journal of Medicine 347 (2), 89-94, 2002 | 1007 | 2002 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 934 | 2021 |
| Primary Sjögren’s syndrome X Mariette, LA Criswell New England Journal of Medicine 378 (10), 931-939, 2018 | 896 | 2018 |
| Sjögren syndrome P Brito-Zerón, C Baldini, H Bootsma, SJ Bowman, R Jonsson, X Mariette, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 885 | 2016 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 878 | 2014 |
| Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three‐year prospective … F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 799 | 2009 |
| High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized … JP Fermand, P Ravaud, S Chevret, M Divine, V Leblond, C Belanger, ... Blood, The Journal of the American Society of Hematology 92 (9), 3131-3136, 1998 | 725 | 1998 |
| The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome X Mariette, S Roux, J Zhang, D Bengoufa, F Lavie, T Zhou, R Kimberly Annals of the rheumatic diseases 62 (2), 168-171, 2003 | 723 | 2003 |
| Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome JE Gottenberg, N Cagnard, C Lucchesi, F Letourneur, S Mistou, T Lazure, ... Proceedings of the National Academy of Sciences 103 (8), 2770-2775, 2006 | 715 | 2006 |
| Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates K Fizazi, A Lipton, X Mariette, JJ Body, Y Rahim, JR Gralow, G Gao, L Wu, ... Journal of Clinical Oncology 27 (10), 1564-1571, 2009 | 652 | 2009 |
| EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 612 | 2020 |
